- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
More Press Releases
Oct 07, 2025
5 Small-cap Biotech ETFs to Watch in 2025
More Featured Articles and Inverviews
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.
Latest News
Latest News
Outlook Reports
Featured Biotech Investing Stocks
Browse Companies
        MARKETS
    
        COMMODITIES
    
        CURRENCIES